HC Wainwright Sets Coherus Oncology Price Target at $7.00 per Share
HC Wainwright & Co. assumed coverage of Coherus Oncology with a Buy rating and announced a $7.00-per-share price target.
HC Wainwright & Co. assumed coverage of Coherus Oncology with a Buy rating and announced a $7.00-per-share price target.